MSEApp News

Ash Biomedical Enters Global Partnership to Strengthen Confidence in Nigeria’s Diagnostic Solutions

Ash Biomedical Enters Global Partnership to Strengthen Confidence in Nigeria’s Diagnostic Solutions

Ash Biomedical Enters Global Partnership to Strengthen Confidence in Nigeria’s Diagnostic Solutions. to introduce the ConfiSign™️ HIV Self-Test to Folalumi Alaran in Abuja Ash Biomedical Diagnostics Ltd., a Nigerian diagnostics manufacturer, has entered into a strategic partnership with South Korea-based GenBody Inc..

Ash Biomedical Enters Global Partnership to Strengthen Confidence in Nigeria’s Diagnostic Solutions.

to introduce the ConfiSign™️ HIV Self-Test to Folalumi Alaran in Abuja Ash Biomedical Diagnostics Ltd., a Nigerian diagnostics manufacturer, has entered into a strategic partnership with South Korea-based GenBody Inc.

to introduce the ConfiSign HIV Self-Test to Nigeria, marking another significant milestone in the company’s drive to expand access to reliable rapid diagnostic solutions while strengthening local healthcare manufacturing capacity.

Under the partnership, Ash Biomedical will serve as GenBody’s strategic partner for local manufacturing and distribution in Nigeria, once its facility has been completed in Idu, FCT.

The ConfiSign HIV Self-Test will be the first globally approved product, which is limited to a few countries, with Nigeria positioned as a potential base for wider West African reach. For Nigerians, the significance goes beyond the arrival of another diagnostic product. The partnership, which will involve technology transfer and training, provides an additional indication of growing confidence in Ash Biomedical’s capabilities, quality systems and ambition to build sustainable diagnostic capacity in Nigeria, at a time when greater local production of essential healthcare products has become increasingly important. The HIV self-test is designed to give individuals greater privacy and convenience in knowing their HIV status, potentially removing some of the barriers that prevent people from seeking testing.

MSEApp News is publishing an original rewrite of this tip for readers, based on reporting associated with THISDAY.